| Previous issue |  > Previous issue |
|
|
|
|
|
- Original Articles
- Radiotherapy, volume reduction, and short-term surgical outcomes in the treatment of large myxoid liposarcomas
- Linus Hyunsuk Lee
 , Sarah Tepper, Grant Owen, Dian Wang, Nicolas Lopez-Hisijos, Matthew W. Colman, Steven Gitelis, Alan T. Blank
-
Radiat Oncol J. 2022;40(3):172-179. Published online September 6, 2022
-
|
Purpose: While tumor volume reduction following radiation has been documented in myxoid liposarcomas, it is unclear whether large tumors experience similar volume reduction to smaller tumors.
Materials and Methods: MRI studies performed before and after completion of pre-operative radiation therapy (RT) were examined. Tumor sizes were noted and categorized as large versus small based on size >10 cm. Tumor volumes... |
-
-
|
- Dosimetric analysis of intracavitary brachytherapy applicators: a practical study
- Aijaz A. Khan
 , Anuj Vijay, Shaqul Qamar Wani, Malik M. Haq
-
Radiat Oncol J. 2022;40(3):180-191. Published online September 8, 2022
-
|
Purpose: Intracavitary brachytherapy is one of the important methods of gynecological cancer treatment. The effect of attenuation is not considered in the dose calculation method released by the American Association of Physicists in Medicine (AAPM) Task Group No. 43 Report (TG-43). In this study, the effect of high-dose rate (HDR) brachytherapy applicators on dose distribution was measured using Gafchromic films... |
-
-
|
- Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
- Ángel L. Sánchez-Iglesias
 , Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
-
Radiat Oncol J. 2022;40(3):192-199. Published online September 27, 2022
-
|
Purpose: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer.
Materials and Methods: We analysed the toxicity and clinical control results obtained in patients with bone-only oligometastatic prostate cancer treated with stereotactic ablative radiotherapy (SABR). Retrospective study on patients with metachronous oligoprogression and synchronous de novo bone-only... |
-
-
|
- A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
- Sergey Nikolaevich Novikov
 , Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
-
Radiat Oncol J. 2022;40(3):200-207. Published online September 30, 2022
-
|
Purpose: To compare biochemical recurrence-free survival (BRFS) and toxicity outcomes of high dose rate brachytherapy (HDRB) and stereotactic body radiotherapy (SBRT) boost after elective nodal irradiation for high/very high-risk prostate cancer.
Materials and Methods: a retrospective analysis was performed in 149 male. In 98 patients, the boost to the prostate was delivered by HDRB as 2 fractions of 10 Gy... |
-
-
|
- Case Report
- Mucoepidermoid carcinoma of the trachea in a 9-year-old male child: case report and review of literature
- Deepak Kumar Uppal, Renu Madan, Nitin J. Peters, Amanjit Bal, Nagarjun Ballari, Shikha Goyal, Divya Khosla
-
Radiat Oncol J. 2022;40(3):208-212. Published online September 29, 2022
-
|
Mucoepidermoid carcinoma (MEC) is most common malignancy of minor salivary glands in adults. Pulmonary MEC is extremely uncommon comprising of only 0.1%–0.2% of the primary lung malignancies and <1% of primary bronchial tumors. It is even rarer in children and literature limited to few case reports only. Here we present a case report of a 9-year-old boy diagnosed with primary... |
-
-
|
|
|
|
